CN114276243A - Synthetic method of loxoprofen and analogs thereof - Google Patents
Synthetic method of loxoprofen and analogs thereof Download PDFInfo
- Publication number
- CN114276243A CN114276243A CN202111513343.4A CN202111513343A CN114276243A CN 114276243 A CN114276243 A CN 114276243A CN 202111513343 A CN202111513343 A CN 202111513343A CN 114276243 A CN114276243 A CN 114276243A
- Authority
- CN
- China
- Prior art keywords
- acid
- compound
- analogues
- organic
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960002373 loxoprofen Drugs 0.000 title claims abstract description 16
- YMBXTVYHTMGZDW-UHFFFAOYSA-N loxoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1CC1C(=O)CCC1 YMBXTVYHTMGZDW-UHFFFAOYSA-N 0.000 title abstract 2
- 238000010189 synthetic method Methods 0.000 title description 3
- 238000006243 chemical reaction Methods 0.000 claims abstract description 43
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000003054 catalyst Substances 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 12
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 11
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 72
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 30
- BAZQYVYVKYOAGO-UHFFFAOYSA-M loxoprofen sodium hydrate Chemical compound O.O.[Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 BAZQYVYVKYOAGO-UHFFFAOYSA-M 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 9
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 8
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 claims description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N oxalic acid group Chemical group C(C(=O)O)(=O)O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- 235000019260 propionic acid Nutrition 0.000 claims description 6
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 150000007524 organic acids Chemical class 0.000 claims description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 4
- 235000011054 acetic acid Nutrition 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 150000007514 bases Chemical class 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 claims description 3
- 239000004324 sodium propionate Substances 0.000 claims description 3
- 235000010334 sodium propionate Nutrition 0.000 claims description 3
- 229960003212 sodium propionate Drugs 0.000 claims description 3
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 claims description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 150000004714 phosphonium salts Chemical class 0.000 claims description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 2
- 235000019265 sodium DL-malate Nutrition 0.000 claims description 2
- 239000001632 sodium acetate Substances 0.000 claims description 2
- 235000017281 sodium acetate Nutrition 0.000 claims description 2
- 229960004249 sodium acetate Drugs 0.000 claims description 2
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 239000001394 sodium malate Substances 0.000 claims description 2
- PRWXGRGLHYDWPS-UHFFFAOYSA-L sodium malonate Chemical compound [Na+].[Na+].[O-]C(=O)CC([O-])=O PRWXGRGLHYDWPS-UHFFFAOYSA-L 0.000 claims description 2
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 claims description 2
- 229940039790 sodium oxalate Drugs 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 2
- 150000002989 phenols Chemical class 0.000 claims 1
- REJGOFYVRVIODZ-UHFFFAOYSA-N phosphanium;chloride Chemical compound P.Cl REJGOFYVRVIODZ-UHFFFAOYSA-N 0.000 claims 1
- 238000011084 recovery Methods 0.000 abstract description 13
- 239000002253 acid Substances 0.000 abstract description 8
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 239000002699 waste material Substances 0.000 abstract description 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 96
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 42
- 238000003756 stirring Methods 0.000 description 41
- 238000001816 cooling Methods 0.000 description 31
- 238000004128 high performance liquid chromatography Methods 0.000 description 29
- 239000012065 filter cake Substances 0.000 description 28
- 239000012074 organic phase Substances 0.000 description 28
- 238000010438 heat treatment Methods 0.000 description 21
- 229910052757 nitrogen Inorganic materials 0.000 description 21
- 239000008346 aqueous phase Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 15
- 238000001035 drying Methods 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 14
- 238000001914 filtration Methods 0.000 description 14
- 238000002386 leaching Methods 0.000 description 14
- 238000004537 pulping Methods 0.000 description 13
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 11
- 239000012071 phase Substances 0.000 description 10
- 238000004821 distillation Methods 0.000 description 8
- 229940126062 Compound A Drugs 0.000 description 7
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 7
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 5
- 229940017219 methyl propionate Drugs 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- ZTXFOCMYRCGSMU-UHFFFAOYSA-M tetramethylphosphanium;bromide Chemical compound [Br-].C[P+](C)(C)C ZTXFOCMYRCGSMU-UHFFFAOYSA-M 0.000 description 3
- KYCQOKLOSUBEJK-UHFFFAOYSA-M 1-butyl-3-methylimidazol-3-ium;bromide Chemical compound [Br-].CCCCN1C=C[N+](C)=C1 KYCQOKLOSUBEJK-UHFFFAOYSA-M 0.000 description 2
- LFVOGMCVFJIJGK-UHFFFAOYSA-N C[NH+]1CC=CC=C1.[Br-] Chemical compound C[NH+]1CC=CC=C1.[Br-] LFVOGMCVFJIJGK-UHFFFAOYSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 108010021119 Trichosanthin Proteins 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- -1 loxoprofen sodium Chemical class 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- BRKFQVAOMSWFDU-UHFFFAOYSA-M tetraphenylphosphanium;bromide Chemical compound [Br-].C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 BRKFQVAOMSWFDU-UHFFFAOYSA-M 0.000 description 2
- GRVPDGGTLNKOBZ-UHFFFAOYSA-M triethyl(methyl)azanium;bromide Chemical compound [Br-].CC[N+](C)(CC)CC GRVPDGGTLNKOBZ-UHFFFAOYSA-M 0.000 description 2
- IAZSXUOKBPGUMV-UHFFFAOYSA-N 1-butyl-3-methyl-1,2-dihydroimidazol-1-ium;chloride Chemical compound [Cl-].CCCC[NH+]1CN(C)C=C1 IAZSXUOKBPGUMV-UHFFFAOYSA-N 0.000 description 1
- FHDQNOXQSTVAIC-UHFFFAOYSA-M 1-butyl-3-methylimidazol-3-ium;chloride Chemical compound [Cl-].CCCCN1C=C[N+](C)=C1 FHDQNOXQSTVAIC-UHFFFAOYSA-M 0.000 description 1
- RPZNPEMXYNMTKB-UHFFFAOYSA-N Br.CCN1CC=CC=C1 Chemical compound Br.CCN1CC=CC=C1 RPZNPEMXYNMTKB-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- YXBSOQIDSJOJRD-UHFFFAOYSA-N C(C=C1)=CC=C1P(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.Br Chemical compound C(C=C1)=CC=C1P(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.Br YXBSOQIDSJOJRD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WJGAPUXHSQQWQF-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O WJGAPUXHSQQWQF-UHFFFAOYSA-N 0.000 description 1
- PZAGQUOSOTUKEC-UHFFFAOYSA-N acetic acid;sulfuric acid Chemical compound CC(O)=O.OS(O)(=O)=O PZAGQUOSOTUKEC-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- AWTHIIUZRKZUJY-UHFFFAOYSA-M methyl(tripropyl)azanium;bromide Chemical class [Br-].CCC[N+](C)(CCC)CCC AWTHIIUZRKZUJY-UHFFFAOYSA-M 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000003003 phosphines Chemical class 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- BBFCIBZLAVOLCF-UHFFFAOYSA-N pyridin-1-ium;bromide Chemical compound Br.C1=CC=NC=C1 BBFCIBZLAVOLCF-UHFFFAOYSA-N 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000006561 solvent free reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- YAXDBEZBVYFNDT-UHFFFAOYSA-M triethyl(hexyl)azanium;chloride Chemical compound [Cl-].CCCCCC[N+](CC)(CC)CC YAXDBEZBVYFNDT-UHFFFAOYSA-M 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/317—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
- C07C67/32—Decarboxylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
Abstract
The invention relates to the field of drug synthesis, in particular to a method for synthesizing loxoprofen and analogues thereof, which has the following reaction formula:
Description
Technical Field
The invention relates to the field of drug synthesis, in particular to a synthetic method of loxoprofen and analogues thereof.
Background
The finished medicine is formed from its sodium salt, i.e. loxoprofen sodium, and is a precursor medicine, and can be absorbed by digestive tract, and converted into active metabolite, and its active metabolite can inhibit synthesis of prostaglandin so as to attain the goal of relieving pain, resisting inflammation and clearing away heat.
The existing loxoprofen synthesis process has one-step hydrolysis decarboxylation reaction, a hydrochloric acid-acetic acid system or a dilute sulfuric acid-acetic acid system is usually adopted for hydrolysis, and mixed acid is not effectively recovered in the post-treatment process, so that a large amount of acid water is wasted and the environment is polluted.
For example, in WO2014167509a2, a mixed (acetic acid-concentrated hydrochloric acid) system of a large excess amount of organic acid and inorganic acid is selected for hydrolysis, and the mixed acid is not effectively recovered in the post-treatment process, so that a large amount of acid water is wasted and the environment is polluted, and even if the mixed acid is recovered, the resource needs to be invested, and the treatment cost is increased.
Disclosure of Invention
The invention provides a method for synthesizing loxoprofen and analogues thereof, which avoids the use of a large amount of acid solution.
The invention adopts the following technical scheme:
a method for synthesizing loxoprofen and analogues thereof is disclosed, wherein the reaction formula is as follows:
the compound I reacts under the catalysis of a catalyst to generate a compound II.
In the above-mentioned technical means, the catalyst is preferably one or a mixture of plural kinds of inorganic metal salts of halogen such as fluorine, chlorine, bromine, iodine, etc., organic ammonium salts, organic phosphonium salts (tetramethylphosphonium bromide, tetraphenylphosphonium bromide, etc.), organic amines (including alkylamine and nitrogen-containing heterocycle), hydrochlorides, hydrobromides, hydroiodides of organic phosphines.
Preferably, the reaction temperature is 100 to 200 ℃.
Preferably, the reaction is carried out in the absence of a solvent or in a solvent having a boiling point above 100 ℃.
The reaction temperature of the reaction in the invention is generally required to reach 100 ℃, and therefore a solvent-free reaction or a solvent having a boiling point exceeding 100 ℃ is selected. The reaction substrate may act as a solvent in a liquid state at high temperature. Dipolar solvent, oxygen-containing solvent, and a small amount of water can effectively increase the solubility of the catalyst so as to accelerate the reaction. In a nonpolar solvent such as toluene, the solubility of the catalyst is lowered, and the reaction rate is relatively slow.
In the above aspect, the solvent having a boiling point of more than 100 ℃ is preferably one or more selected from DMF (N, N-dimethylformamide), DMAC (N, N-dimethylacetamide), NMP (N-methylpyrrolidone), DMSO (dimethyl sulfoxide), toluene, xylene, chlorobenzene, ethylene glycol diethyl ether, diethylene glycol dimethyl ether, and the like.
When organic acid such as oxalic acid, acetic acid, propionic acid, butyric acid, malonic acid, malic acid, citric acid and the like or acidic organic matter such as phenol, p-nitrophenol and the like are added into a reaction system in an equivalent or excessive amount, the catalyst can be recycled and reused. Or when an equivalent or excess amount of a metal salt of an organic acid such as an organic amine (including an alkylamine and a nitrogen-containing heterocycle), an organic phosphine, sodium oxalate, sodium acetate, sodium propionate, sodium butyrate, disodium malonate, sodium malate, or sodium citrate, or a basic compound such as a metal salt of a phenol compound such as phenol or p-nitrophenol is added to the reaction system, the catalyst can be recovered and used.
Preferably, a small amount of water is added to the reaction system to facilitate the reaction.
Through the implementation of the technical scheme, compared with the prior art, the invention has the following advantages:
the invention avoids the use of a large amount of acid solution.
The invention can be carried out under the condition of no solvent, and is more green and environment-friendly.
The catalyst used by the method can be recycled, the recovery rate of the catalyst reaches 98 percent, and the three-waste discharge and the environmental pollution are greatly reduced.
Detailed Description
The implementation procedures and the resulting advantages described in detail below by specific examples are intended to help the reader to better understand the essence and features of the present invention, and are not intended to limit the implementable scope of the present invention.
Example 1
Adding 0.5 mol of the compound A into a 500mL four-neck flask, adding 0.5 mol of NaBr, adding 200g of DMF, replacing with nitrogen, heating to the internal temperature of 130-150 ℃, keeping the temperature for reacting for 8-9 h, then completely reacting, cooling to 60-80 ℃, and distilling 160-180 g of DMF under reduced pressure. After the distillation, cooling to the internal temperature of 10-20 ℃, adding 200g of water and 600g of ethyl acetate, stirring and extracting, and separating a lower water phase. Adding 100g of water into the organic phase, stirring and separating the lower-layer water phase, and concentrating the organic phase under reduced pressure at the temperature of 30-50 ℃ in a water bath to obtain 125.4g of brown oil-like compound B, wherein the yield is 96.3%, and the purity is 97.2% by HPLC (high performance liquid chromatography).
Example 2
Adding 0.5 mol of the compound A into a 500mL four-neck flask, adding 0.5 mol of NaBr, adding 200g of DMF, adding 0.5 mol of water, replacing with nitrogen, heating to an internal temperature of 130-150 ℃, keeping the temperature for reaction for 7-8 h, then completely reacting, cooling to an internal temperature of 60-80 ℃, and distilling 160-180 g of DMF under reduced pressure. After the distillation, cooling to the internal temperature of 10-20 ℃, adding 200g of water and 600g of ethyl acetate, stirring and extracting, and separating a lower water phase. Adding 100g of water into the organic phase, stirring and separating the lower-layer water phase, and concentrating the upper-layer organic phase in a water bath at 30-50 ℃ under reduced pressure to obtain 123.3g of brown oil-like compound B, wherein the yield is 94.7%, and the purity is 96.6% by HPLC (high performance liquid chromatography).
Example 3
In a 500mL four-necked flask, 0.5 mol of Compound A and 0.25 mol of NiBr were added2Adding 200g of DMSO (dimethyl sulfoxide), replacing with nitrogen, heating to the internal temperature of 140-160 ℃, keeping the temperature for reaction for 12-13 h, completely reacting, cooling to the internal temperature of 60-80 ℃, and distilling 160-180 g of DMF under reduced pressure. After the distillation, cooling to the internal temperature of 10-20 ℃, adding 200g of water and 600g of ethyl acetate, stirring and extracting, and separating a lower water phase. Adding 100g of water into the organic phase, stirring and separating the lower aqueous phase, and concentrating the upper organic phase in a water bath at 30-50 ℃ under reduced pressure to obtain 121.1g of brown oil-like compound B, wherein the yield is 93.0%, and the purity is 96.8% by HPLC (high performance liquid chromatography).
Example 4
Adding 0.5 mol of the compound A into a 500mL four-neck flask, adding 0.5 mol of tetrabutylammonium bromide, adding 200g of DMF, replacing with nitrogen, heating to an internal temperature of 130-150 ℃, keeping the temperature for reaction for 5-6 h, then completely reacting, cooling to an internal temperature of 60-80 ℃, and distilling 160-180 g of DMF under reduced pressure. Cooling to an internal temperature of 10-20 ℃ after the steaming, and adding 200g of water and
600g of ethyl acetate are extracted with stirring, and the lower aqueous phase is separated off. Adding 100g of water into the organic phase, stirring and separating the lower-layer water phase, and concentrating the upper-layer organic phase under reduced pressure at 30-50 ℃ in a water bath to obtain 115.3 g of brown oily compound B, wherein the yield is 88.6%, and the purity is 97.4% by HPLC (high performance liquid chromatography).
Example 5
Adding 0.5 mol of the compound A into a 500mL four-neck flask, adding 0.5 mol of tetraethylammonium bromide, adding 200g of NMP, replacing with nitrogen, heating to an internal temperature of 130-150 ℃, keeping the temperature for reaction for 5-6 h, then completely reacting, cooling to an internal temperature of 60-80 ℃, and distilling 160-180 g of DMF under reduced pressure. Cooling to an internal temperature of 10-20 ℃ after the steaming, and adding 200g of water and
600g of ethyl acetate are extracted with stirring, and the lower aqueous phase is separated off. Adding 100g of water into the organic phase, stirring and separating the lower-layer water phase, and concentrating the upper-layer organic phase under reduced pressure at 30-50 ℃ in a water bath to obtain 117.7 g of brown oily compound B, wherein the yield is 90.4%, and the purity is 98.1% by HPLC (high performance liquid chromatography).
Example 6
Adding 0.5 mol of compound C into a 500mL four-neck flask, adding 0.5 mol of 1-butyl-3-methylimidazolium bromide, adding 300g of toluene, replacing with nitrogen, heating to reflux, keeping the temperature for reaction for 24-30 h, then completely reacting, cooling to the internal temperature of 10-20 ℃, adding 200g of water, stirring and extracting, and removing the lower-layer water phase. Adding 100g of water into the organic phase, stirring and separating the lower aqueous phase, and concentrating the upper organic phase under reduced pressure at 40-60 ℃ in a water bath to obtain 126.1g of brown oil-like compound D, wherein the yield is 91.9%, and the purity is 98.3% by HPLC (high performance liquid chromatography).
Example 7
Adding 0.5 mol of compound C into a 500mL four-necked bottle, adding 0.5 mol of 1-butyl-3-methylimidazolium bromide, adding 300g of ethylene glycol diethyl ether, replacing with nitrogen, heating to reflux, keeping the temperature for reaction for 24-30 h, reacting completely, cooling to an internal temperature of 60-80 ℃, and distilling 260-280 g of ethylene glycol diethyl ether under reduced pressure. After the distillation, cooling to the internal temperature of 10-20 ℃, adding 200g of water and 600g of ethyl acetate, stirring and extracting, and separating a lower water phase. Adding 100g of water into the organic phase, stirring and separating the lower-layer water phase, and concentrating the upper-layer organic phase under reduced pressure at 30-50 ℃ in a water bath to obtain 123.7 g of brown oily compound D, wherein the yield is 90.2%, and the purity is 98.4% by HPLC (high performance liquid chromatography).
Example 8
Adding 0.5 mol of compound C into a 500mL four-neck flask, adding 0.1 mol of 1-butyl-3-methylimidazolium chloride, adding 300g of ethylene glycol diethyl ether, adding 0.55mol of acetic acid, heating to reflux after nitrogen replacement, separating the methyl acetate evaporated in the reaction process by a water separator, reacting completely after heat preservation for 24-30 h, cooling to the internal temperature of 50-70 ℃, and evaporating 260-280 g of ethylene glycol diethyl ether under reduced pressure. After the distillation is finished, cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 17.2 g of recovered 1-butyl-3-methylimidazole hydrochloride, wherein the recovery rate is 98.5%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 125.2 g brown oily compound D, with yield of 91.3% and purity of 98.5% as detected by HPLC.
Example 9
Adding 0.5 mol of compound C into a 500mL four-neck flask, adding 0.5 mol of tetrabutylammonium bromide, adding 300g of chlorobenzene, adding 0.3mol of malonic acid, replacing with nitrogen, heating to reflux, and reacting for 10-12 h under heat preservation to complete the reaction. And cooling to the internal temperature of 10-20 ℃, filtering, leaching a filter cake with 100g of chlorobenzene, transferring the filter cake to a vacuum oven at 40-50 ℃, and drying for 12-16 h to obtain 158.4 g of recovered tetrabutylammonium bromide, wherein the recovery rate is 98.3%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 40-60 deg.c and decompression to obtain brown oily compound D in the yield of 93.7% and HPLC purity of 98.7%.
Example 10
Adding 0.5 mol of the compound E into a 500mL four-neck flask, adding 0.2mol of triethylmethylammonium bromide, adding 300g of diethylene glycol dimethyl ether, adding 0.55mol of propionic acid, replacing with nitrogen, heating to reflux, separating the methyl propionate evaporated in the reaction process by a water separator, keeping the temperature for reaction for 24-30 h, completely reacting, cooling to the internal temperature of 50-70 ℃, and evaporating 260-280 g of diethylene glycol dimethyl ether under reduced pressure. After the distillation is finished, cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 38.3 g of recovered triethyl methyl ammonium bromide, wherein the recovery rate is 98.2%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 128.2 g brown oily compound D with yield of 93.5% and purity of 97.3% by HPLC.
Example 11
Adding 0.5 mol of the compound E into a 500mL four-mouth bottle, adding 0.1 mol of hexadecyl trimethyl ammonium bromide, adding 0.55mol of butyric acid, replacing with nitrogen, heating to the internal temperature of 160-165 ℃, and keeping the temperature to react for 6-8 h to complete the reaction. Cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 33.1g of recovered hexadecyl trimethyl ammonium bromide, wherein the recovery rate is 98.4%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. And concentrating the upper organic phase in a water bath at 30-50 ℃ under reduced pressure to obtain 129.2 g of brown oily compound D, wherein the yield is 94.2%, and the purity is 98.3% by HPLC (high performance liquid chromatography).
Example 12
Adding 0.5 mol of compound C into a 500mL four-neck flask, adding 0.1 mol of triethylamine hydrochloride, adding 300g of DMSO, replacing with nitrogen, heating to the internal temperature of 160-170 ℃, keeping the temperature for reacting for 16-18 h, then completely reacting, cooling to the internal temperature of 60-80 ℃, and distilling 260-280 g of DMSO under reduced pressure. After the distillation is finished, cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 19.2 g of recovered triethyl hexyl ammonium chloride, wherein the recovery rate is 98.5%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 119.2 g brown oily compound D with yield of 87.0% and purity of 96.1% by HPLC.
Example 13
Adding 0.5 mol of the compound F into a 500mL four-neck flask, adding 0.1 mol of pyridine hydrobromide, adding 0.2mol of malic acid, adding 300g of DMF, replacing with nitrogen, heating to the internal temperature of 135-145 ℃, keeping the temperature, reacting for 6-8 h, and then completely reacting. Cooling to an internal temperature of 50-70 ℃, and distilling 260-280 g of DMF under reduced pressure. After the distillation is finished, cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 18.5g of recovered N-ethylpyridine bromide, wherein the recovery rate is 98.4%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 133.1G brown oily compound G with yield of 92.4% and purity of 96.7% by HPLC.
Example 14
Adding 0.5 mol of compound H, 0.1 mol of tetramethyl phosphonium bromide and 0.55mol of propionic acid into a 500mL four-necked bottle, heating to the internal temperature of 140-150 ℃ after nitrogen replacement, separating the methyl propionate evaporated in the reaction process by a water separator, and reacting for 16-18H under the condition of heat preservation to complete the reaction. Cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 16.8 g of recovered tetramethyl phosphonium bromide, wherein the recovery rate is 98.2%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 138.4 g brown oily compound J with yield of 91.5% and purity of 97.9% by HPLC.
Example 15
Adding 0.5 mol of compound K, 0.06 mol of tetraphenyl phosphine bromide and 0.55mol of acetic acid into a 500mL four-necked bottle, heating to the internal temperature of 130-140 ℃ after nitrogen replacement, connecting a water separator to separate the methyl acetate evaporated in the reaction process, and keeping the temperature to react for 6-8 h to complete the reaction. Cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 24.8g of recovered tetraphenyl phosphonium bromide, wherein the recovery rate is 96.3%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 152.3 g brown oily compound L with yield of 92.2% and purity of 97.9% by HPLC.
Example 16
Adding 0.5 mol of the compound A into a 500mL four-neck flask, adding 0.1 mol of tetrabutylammonium bromide, adding 0.55mol of sodium propionate, replacing with nitrogen, heating to the internal temperature of 140-150 ℃, separating the methyl propionate evaporated in the reaction process by a water separator, and reacting for 16-18 h under the condition of heat preservation to complete the reaction. Cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 31.0 g of recovered tetrabutylammonium bromide, wherein the recovery rate is 96.2%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 122.3 g brown oily compound B with yield of 94.0% and purity of 97.6% by HPLC.
Example 17
Adding 0.5 mol of the compound A into a 500mL four-neck flask, adding 0.1 mol of tetrabutylammonium bromide, adding 0.55mol of n-propylamine, replacing with nitrogen, heating to the internal temperature of 130-140 ℃, and keeping the temperature to react for 12-14 h to complete the reaction. Cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven at 40-50 ℃, drying for 12-16 h to obtain 27.8g of recovered tetrabutylammonium bromide and tri-n-propylmethylammonium bromide compounds, and recovering 86.2%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 120.1 g brown oily compound B with yield of 92.3% and purity of 95.8% by HPLC.
Example 18
Adding 0.5 mol of compound M into a 500mL four-neck flask, adding 0.1 mol of tetraethylammonium bromide, adding 0.55mol of propionic acid, replacing with nitrogen, heating to the internal temperature of 140-150 ℃, separating the methyl propionate evaporated in the reaction process by a water separator, and reacting for 16-18 h under the condition of heat preservation to complete the reaction. Cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 19.8 g of recovered tetraethylammonium bromide, wherein the recovery rate is 94.2%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.c and decompression to obtain brown oily compound N in the yield of 96.6% and HPLC purity of 95.4%.
Example 19
Adding 0.5 mol of compound P, 0.1 mol of tetrabutylammonium bromide and 0.55mol of pyridine into a 500mL four-neck flask, replacing with nitrogen, heating to the internal temperature of 130-140 ℃, and keeping the temperature for reaction for 10-12 h to complete the reaction. Cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven at 40-50 ℃, drying for 12-16 h to obtain 28.8g of recovered tetrabutylammonium bromide and N-methylpyridine bromide, and recovering 89.4%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 110.6 g brown oily compound Q with yield of 97.3% and purity of 94.3% by HPLC.
Example 20
Adding 0.5 mol of compound M into a 500mL four-neck flask, adding 21.0g of recovered tetraethylammonium bromide, adding 0.55mol of propionic acid, replacing with nitrogen, heating to the internal temperature of 140-150 ℃, connecting a water separator to separate the methyl propionate evaporated in the reaction process, and keeping the temperature for reacting for 16-18 h to complete the reaction. Cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven for drying at 40-50 ℃ for 12-16 h to obtain 20.1 g of recovered tetraethylammonium bromide, wherein the recovery rate is 95.7%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 108.4 g brown oily compound N with yield of 95.4% and purity of 96.7% by HPLC.
Example 21
Adding 0.5 mol of the compound P into a 500mL four-neck flask, adding 32.2g of recovered tetrabutylammonium bromide, adding 0.55mol of pyridine, replacing with nitrogen, heating to the internal temperature of 130-140 ℃, and keeping the temperature for reaction for 10-12 h to complete the reaction. Cooling to the internal temperature of 10-20 ℃, adding 500 g of ethyl acetate, stirring, pulping and filtering, leaching a filter cake with 100g of ethyl acetate, transferring the filter cake to a vacuum oven at 40-50 ℃, drying for 12-16 h to obtain 27.4g of a recovered tetrabutylammonium bromide and N-methylpyridine bromide salt mixture, and recovering 85.1%. 100g of water was added to the filtrate, and the mixture was extracted with stirring to separate the lower aqueous phase. Concentrating the upper organic phase in water bath at 30-50 deg.C under reduced pressure to obtain 110.6 g brown oily compound Q with yield of 97.3% and purity of 94.3% by HPLC.
Claims (10)
2. The method for synthesizing loxoprofen and the analogues thereof according to claim 1, wherein the catalyst is one or more of halogen, inorganic metal salt, organic ammonium salt, organic phosphonium salt, organic amine, organic phosphine hydrochloride, hydrobromide or hydroiodide.
3. The method for synthesizing loxoprofen and analogues thereof according to claim 1, wherein the reaction temperature is 100-200 ℃.
4. The method for synthesizing loxoprofen and its analogues according to claim 1, wherein the reaction is carried out in the absence of a solvent or in a solvent having a boiling point exceeding 100 ℃.
5. The method as claimed in claim 4, wherein the solvent with boiling point over 100 ℃ is one or more of DMF (N, N-dimethylformamide), DMAC (N, N-dimethylacetamide), NMP (N-methylpyrrolidone), DMSO (dimethyl sulfoxide), toluene, xylene, chlorobenzene, ethylene glycol diethyl ether, and diethylene glycol dimethyl ether.
6. The method for synthesizing loxoprofen and analogues thereof according to claim 2, wherein said catalyst is recovered by using an acidic organic substance or a metal salt of an organic acid or a basic compound.
7. The method as claimed in claim 6, wherein the acidic organic substance is oxalic acid, acetic acid, propionic acid, butyric acid, malonic acid, malic acid, citric acid, phenol or p-nitrophenol.
8. The method for synthesizing loxoprofen and analogues thereof according to claim 6, wherein said metal salt of organic acid is organic amine, organic phosphine, sodium oxalate, sodium acetate, sodium propionate, sodium butyrate, disodium malonate, sodium malate or sodium citrate.
9. The method for synthesizing loxoprofen and analogues thereof as claimed in claim 6, wherein said basic compound is a metal salt of phenolic compound.
10. The method for synthesizing loxoprofen and analogues thereof according to claim 1, wherein water is added to the reaction system.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111513343.4A CN114276243A (en) | 2021-12-13 | 2021-12-13 | Synthetic method of loxoprofen and analogs thereof |
PCT/CN2021/139085 WO2023108601A1 (en) | 2021-12-13 | 2021-12-17 | Synthesis method for loxoprofen and analogues thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111513343.4A CN114276243A (en) | 2021-12-13 | 2021-12-13 | Synthetic method of loxoprofen and analogs thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114276243A true CN114276243A (en) | 2022-04-05 |
Family
ID=80872007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111513343.4A Pending CN114276243A (en) | 2021-12-13 | 2021-12-13 | Synthetic method of loxoprofen and analogs thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114276243A (en) |
WO (1) | WO2023108601A1 (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001081066A (en) * | 1999-09-10 | 2001-03-27 | Nippon Petrochem Co Ltd | Substituted styrene derivative |
JP4074341B2 (en) * | 1995-12-29 | 2008-04-09 | 日本ゼオン株式会社 | Method for producing carbonyl group-containing compound |
CN101412670A (en) * | 2007-10-19 | 2009-04-22 | 浙江普洛医药科技有限公司 | Method for synthesizing loxoprofen sodium |
CN103189337A (en) * | 2010-08-13 | 2013-07-03 | Abbvie德国有限责任两合公司 | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
CN103449946A (en) * | 2013-09-04 | 2013-12-18 | 黄山学院 | Preparation method of alpha-monochlorinated ketone compound |
CN104591989A (en) * | 2015-01-05 | 2015-05-06 | 上海华谊(集团)公司 | Method for preparing 5-[(4-chlorophenyl)methyl]-2,2-dimethyl-cyclopentanone |
WO2015075981A1 (en) * | 2013-11-22 | 2015-05-28 | 株式会社クレハ | Method for producing carbonyl compound |
CN104684881A (en) * | 2012-11-27 | 2015-06-03 | 株式会社吴羽 | Production method for carbonyl compound |
CN108083967A (en) * | 2017-12-27 | 2018-05-29 | 安徽金善化工科技有限公司 | A kind of distillation recovery method of toluene |
CN108440274A (en) * | 2018-03-06 | 2018-08-24 | 大桐制药(中国)有限责任公司 | A kind of synthetic method of high-purity nonsteroidal anti-inflammatory drug loxoprofen sodium |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104326903A (en) * | 2014-10-14 | 2015-02-04 | 合肥远志医药科技开发有限公司 | Industrial production method of high purity loxoprofen sodium dehydrate |
CN104710309A (en) * | 2015-02-05 | 2015-06-17 | 浙江普洛医药科技有限公司 | Synthetic methods of loxoprofen sodium and intermediate thereof |
-
2021
- 2021-12-13 CN CN202111513343.4A patent/CN114276243A/en active Pending
- 2021-12-17 WO PCT/CN2021/139085 patent/WO2023108601A1/en unknown
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4074341B2 (en) * | 1995-12-29 | 2008-04-09 | 日本ゼオン株式会社 | Method for producing carbonyl group-containing compound |
JP2001081066A (en) * | 1999-09-10 | 2001-03-27 | Nippon Petrochem Co Ltd | Substituted styrene derivative |
CN101412670A (en) * | 2007-10-19 | 2009-04-22 | 浙江普洛医药科技有限公司 | Method for synthesizing loxoprofen sodium |
CN103189337A (en) * | 2010-08-13 | 2013-07-03 | Abbvie德国有限责任两合公司 | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
CN104684881A (en) * | 2012-11-27 | 2015-06-03 | 株式会社吴羽 | Production method for carbonyl compound |
CN103449946A (en) * | 2013-09-04 | 2013-12-18 | 黄山学院 | Preparation method of alpha-monochlorinated ketone compound |
WO2015075981A1 (en) * | 2013-11-22 | 2015-05-28 | 株式会社クレハ | Method for producing carbonyl compound |
CN104591989A (en) * | 2015-01-05 | 2015-05-06 | 上海华谊(集团)公司 | Method for preparing 5-[(4-chlorophenyl)methyl]-2,2-dimethyl-cyclopentanone |
CN108083967A (en) * | 2017-12-27 | 2018-05-29 | 安徽金善化工科技有限公司 | A kind of distillation recovery method of toluene |
CN108440274A (en) * | 2018-03-06 | 2018-08-24 | 大桐制药(中国)有限责任公司 | A kind of synthetic method of high-purity nonsteroidal anti-inflammatory drug loxoprofen sodium |
Non-Patent Citations (1)
Title |
---|
ATUL GUPTA ET AL.: "Simple and Efficient Synthesis of Steroidal Hybrids of Estrogen and Vitamin D3", 《SYNTHETIC COMMUNICATIONS》, vol. 39, pages 61 - 69 * |
Also Published As
Publication number | Publication date |
---|---|
WO2023108601A1 (en) | 2023-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107915586B (en) | Phenol compound and preparation method thereof | |
FI63927C (en) | FOERFARANDE FOER FRAMSTAELLNING AV DI-N-PROPYL-AETTIKSSYRA OCHDESS SALTER | |
CN103724261A (en) | Novel industrial production method for hydroxychloroquine sulfate | |
KR102233455B1 (en) | Method for preparation of intermediate of 4-methoxypyrrole derivative | |
CN111303018A (en) | Synthetic method of omeprazole intermediate | |
CN102731349B (en) | Aromatic sulfinic acid compound preparation method | |
KR102233456B1 (en) | Method for preparation of intermediate of 4-methoxypyrrole derivative | |
CN114276243A (en) | Synthetic method of loxoprofen and analogs thereof | |
CN109503513B (en) | One-pot synthesis method of febuxostat intermediate | |
KR101705210B1 (en) | Method of preparing composition of chlorohydrins and method of preparing epichlorohydrin using composition of chlorohydrins prepared by the same | |
KR101705206B1 (en) | Method of preparing chlorohydrins and method of preparing epichlorohydrin using chlorohydrins prepared by the same | |
CN111253276B (en) | Preparation method of oseltamivir phosphate | |
US7741518B2 (en) | Method for producing trifluoromethanesulfonic anhydride | |
WO2012002650A2 (en) | Method for preparing chlorohydrins composition and method for preparing epichlorohydrin using chlorohydrins composition prepared thereby | |
CN108467410B (en) | Preparation method, product and application of TAF intermediate | |
KR101705209B1 (en) | Method of preparing composition of chlorohydrins and method of preparing epichlorohydrin using composition of chlorohydrins prepared by the same | |
CN115093339A (en) | Synthetic method of L-glufosinate-ammonium intermediate | |
CN109824687B (en) | Novel synthetic method of xylofuranose derivative | |
CN109053800B (en) | Quaternary phosphonium salt supported chiral amino-thiourea and preparation method and application thereof | |
KR101705207B1 (en) | Method of preparing chlorohydrins and method of preparing epichlorohydrin using chlorohydrins prepared by the same | |
CN111646907B (en) | Preparation method of 2, 3-dichloro-6-nitroaniline | |
JP2001515496A (en) | Method for producing 5-aminomethyl-chloropyridines | |
CN111440079A (en) | Synthesis method of D L-threo-p-chlorophenylserine | |
CN101665427B (en) | Process for preparing 5-bromo-n-valeryl bromide | |
CN113105419B (en) | Method for preparing S-citalopram from R-diol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220405 |
|
RJ01 | Rejection of invention patent application after publication |